Skip to main content
ADCT
NYSE Life Sciences

ADC Therapeutics Shares Plunge 38% on Zynlonta Trial Safety Concerns, Cost Cut Plans

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.8
Mkt Cap
$391.749M
52W Low
$2.55
52W High
$4.98
52W Position info
29% below low
Off High info
64% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

ADCT is trading near its 52-week low of $2.55 (29% below the low).

Summary

ADC Therapeutics shares plunged 38% after-hours following the release of full Phase 3 LOTIS-5 trial data for its lymphoma drug, Zynlonta. While the drug met its primary endpoint for progression-free survival, the data showed a higher rate of serious adverse events and Grade 5 treatment emergent adverse events. This more complete data follows earlier reports today that only highlighted the positive primary endpoint. The company also announced it will evaluate near-term cost reductions and other value-maximizing alternatives, signaling financial pressure. The safety concerns complicate the path to FDA approval and commercial success for Zynlonta, a critical asset for the company.

At the time of this announcement, ADCT was trading at $1.80 on NYSE in the Life Sciences sector, with a market capitalization of approximately $391.7M. The 52-week trading range was $2.55 to $4.98. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ADCT - Latest Insights

ADCT
Nov 09, 2026, 8:06 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.75
Real-time Price: $1.37 info
Change: -$0.376 (-22%) info
Market Cap: $192.707M info
ADCT
Nov 09, 2026, 7:30 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.58
Real-time Price: $1.37 info
Change: -$0.210 (-13%) info
Market Cap: $192.707M info
ADCT
Nov 04, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.72
Real-time Price: $1.37 info
Change: -$0.350 (-20%) info
Market Cap: $192.707M info
ADCT
Nov 03, 2026, 5:02 PM EST
Filing Type: S-4
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $1.37 info
Change: -$0.180 (-12%) info
Market Cap: $192.707M info
ADCT
Oct 13, 2026, 6:26 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.82
Real-time Price: $1.37 info
Change: -$0.450 (-25%) info
Market Cap: $192.707M info